Ovarian cancer (OC) is the fifth most common cause of cancer-related mortality worldwide and represents the leading cause of death for gynecological malignancies. Nevertheless, over the last years, ...
The mechanism of action for EIS-12656 is similar ... EIS-12656 is currently being assessed as a monotherapy against HRD-positive tumours in the Phase I/II MATCH trial, and compared against a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback